Loading…
Reported covered position: Legislative Director, Rep. Jay Inslee
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Health Flexible Spending Arrangements Improvements Act of 2012
Client: WEX HEALTH · Firm: THE MCMANUS GROUP
Support for H.R. 436, Health Care Cost Reduction Act of 2012, H.R. 1004, Medical FSA Improvement Act of 2011 and S.1404, Medical FSA Improvement Act of 2011.
Health Flexible Spending Arrangements Improvements Act of 2012
Client: WEX HEALTH · Firm: THE MCMANUS GROUP
HR 1004 "The Medical Flexible Spending Account Improvement Act of 2011," S 1404, "Medical FSA Improvement Act of 2011."
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMBULATORY SURGERY CENTER ASSOCIATION via THE MCMANUS GROUP
2012 · fourth_quarter · Q4
Reform of Medicare payments to, and quality reporting of, ambulatory surgery centers. Support for H.R. 2108 and S. 1173, "Ambulatory Surgery Center Quality and Access Act of 2011." Title VI of HR 8, "American Taxpayer Relief Act of 2012."
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN OCCUPATIONAL THERAPY ASSOCIATION via THE MCMANUS GROUP
2012 · fourth_quarter · Q4
Source: Senate LDA
| GENENTECH |
| 16 |
| 2009–2012 |
| MEDICAL DEVICE MANUFACTURERS ASSOCIATION | 16 | 2009–2012 |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 16 | 2009–2012 |
| WEX HEALTH | 16 | 2009–2012 |
| GARY AND MARY WEST HEALTH INSTITUTE | 11 | 2010–2012 |
| LARGE UROLOGY GROUP PRACTICE ASSOCIATION | 9 | 2011–2012 |
| SPIRACUR INC. | 8 | 2011–2012 |
| PEDIATRIX MEDICAL GROUP (MEDNAX NATIONAL MEDICAL GROUP) | 5 | 2012 |
| TRANSONIC SYSTEMS | 4 | 2009 |
| VOLCANO CORPORATION | 3 | 2009–2010 |
Health Flexible Spending Arrangements Improvements Act of 2012
Client: WEX HEALTH · Firm: THE MCMANUS GROUP
Support for H.R. 436, Health Care Cost Reduction Act of 2012, H.R. 1004, Medical FSA Improvement Act of 2011 and S.1404, Medical FSA Improvement Act of 2011.
Health Flexible Spending Arrangements Improvements Act of 2012
Client: WEX HEALTH · Firm: THE MCMANUS GROUP
Support for H.R. 436, Health Care Cost Reduction Act of 2012, H.R. 1004, Medical FSA Improvement Act of 2011 and S.1404, Medical FSA Improvement Act of 2011.
Medicare Access to Rehabilitation Services Act of 2011
Client: AMERICAN OCCUPATIONAL THERAPY ASSOCIATION · Firm: THE MCMANUS GROUP
Therapy cap provisions in H.R. 1546, "Medicare Access to Rehabilitation Services Act of 2011" and S. 829, "Medicare Access to Rehabilitation Services Act of 2011." Implementation of P.L. 112-96, "Middle Class Tax Relief and Job Creation Act of 2012," regarding therapy cap reforms.
Medicare Access to Rehabilitation Services Act of 2011
Client: AMERICAN OCCUPATIONAL THERAPY ASSOCIATION · Firm: THE MCMANUS GROUP
Therapy cap provisions in H.R. 1546, "Medicare Access to Rehabilitation Services Act of 2011" and S. 829, "Medicare Access to Rehabilitation Services Act of 2011." Therapy cap provisions in H.R. 3630, "Middle Class Tax Relief & Job Creation Act of 2012."
Medicare Access to Rehabilitation Services Act of 2011
Client: AMERICAN OCCUPATIONAL THERAPY ASSOCIATION · Firm: THE MCMANUS GROUP
Therapy cap provisions in H.R. 1546, "Medicare Access to Rehabilitation Services Act of 2011" and S. 829, "Medicare Access to Rehabilitation Services Act of 2011." Implementation of P.L. 112-96, "Middle Class Tax Relief and Job Creation Act of 2012," regarding therapy cap reforms.
Medicare Access to Rehabilitation Services Act of 2011
Client: AMERICAN OCCUPATIONAL THERAPY ASSOCIATION · Firm: THE MCMANUS GROUP
Therapy cap provisions in H.R. 1546, "Medicare Access to Rehabilitation Services Act of 2011" and S. 829, "Medicare Access to Rehabilitation Services Act of 2011." Implementation of P.L. 112-96, "Middle Class Tax Relief and Job Creation Act of 2012," regarding therapy cap reforms.
Ambulatory Surgical Center Quality and Access Act of 2011
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Reform of Medicare payments to, and quality reporting of, ambulatory surgery centers. Support for H.R. 2108 and S. 1173, "Ambulatory Surgery Center Quality and Access Act of 2011."
Ambulatory Surgical Center Quality and Access Act of 2011
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Reform of Medicare payments to, and quality reporting of, ambulatory surgery centers. Support for H.R. 2108 and S. 1173, "Ambulatory Surgery Center Quality and Access Act of 2011." Title VI of HR 8, "American Taxpayer Relief Act of 2012."
Ambulatory Surgical Center Quality and Access Act of 2011
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Reform of Medicare payments to, and quality reporting of, ambulatory surgery centers. Support for H.R. 2108 and S. 1173, "Ambulatory Surgery Center Quality and Access Act of 2011." Drug shortage issues.
Ambulatory Surgical Center Quality and Access Act of 2011
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Reform of Medicare payments to, and quality reporting of, ambulatory surgery centers. Support for H.R. 2108 and S. 1173, "Ambulatory Surgery Center Quality and Access Act of 2011." Drug shortage issues.
Generating Antibiotic Incentives Now Act of 2011
Client: AMERICAN MEDICAL ASSOCIATION · Firm: THE MCMANUS GROUP
Support for HR 5, "Protecting Access to Healthcare Act." Drug shortage issues. Issues relating to antibiotic development incentives in HR 2182 and S 1734, "Generating Antibiotic Incentives Now Act of 2011" (GAIN Act).
Generating Antibiotic Incentives Now Act of 2011
Client: GENENTECH · Firm: THE MCMANUS GROUP
FDA approval and enforcement issues. Issues relating to S.3187, Food and Drug Administration Safety and Innovation Act. Issues relating to antibiotic development incentives in HR 2182 and S 1734, "Generating Antibiotic Incentives Now Act of 2011" (GAIN Act). Skin cancer awareness.
Generating Antibiotic Incentives Now Act of 2011
Client: GENENTECH · Firm: THE MCMANUS GROUP
FDA approval and enforcement issues. PDUFA reauthorization. Issues relating to antibiotic development incentives in HR 2182 and S 1734, "Generating Antibiotic Incentives Now Act of 2011" (GAIN Act).
Novel Device Regulatory Relief Act of 2011
Client: GARY AND MARY WEST HEALTH INSTITUTE · Firm: THE MCMANUS GROUP
FDA approval issues. De Novo reform and support for H.R. 3203, "Novel Device Regulatory Relief Act of 2011." MDUFA reauthorization. Support for Section 721 of the House MDUFA draft and Section 611 of the Senate MDUFA draft. Support for S. 2067, "Safe, Efficient, and Transparent Medical Device Approval Act." Congressional oversight of the memorandum of understanding between the FDA and FCC.
Support for H.R. 3497, "MODDERN Cures Act of 2011." PDUFA reauthorization. Drug shortage issues. BPCA and PREA reauthorization.
Support for H.R. 436, Health Care Cost Reduction Act of 2012, H.R. 1004, Medical FSA Improvement Act of 2011 and S.1404, Medical FSA Improvement Act of 2011.
Health Care Cost Reduction Act of 2012
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: THE MCMANUS GROUP
Support for H.R. 436, Health Care Cost Reduction Act of 2012, and S.17, Medical Device Access and Innovation Protection Act.
Health Care Cost Reduction Act of 2012
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: THE MCMANUS GROUP
Support for H.R. 436, Health Care Cost Reduction Act of 2012, and S.17, Medical Device Access and Innovation Protection Act.
Support for H.R. 436, Health Care Cost Reduction Act of 2012, and S.17, Medical Device Access and Innovation Protection Act.
Support for H.R. 436, "Protect Medical Innovation Act" and S.17, "Medical Device Access and Innovation Protection Act."
Support for H.R. 436, Health Care Cost Reduction Act of 2012, H.R. 1004, Medical FSA Improvement Act of 2011 and S.1404, Medical FSA Improvement Act of 2011.
Health Care Cost Reduction Act of 2012
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: THE MCMANUS GROUP
Support for H.R. 436, Health Care Cost Reduction Act of 2012, and S.17, Medical Device Access and Innovation Protection Act.
Health Care Cost Reduction Act of 2012
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: THE MCMANUS GROUP
Support for H.R. 436 "Protect Medical Innovation Act," S. 17 "Medical Device Access and Innovation Protection Act," and S. 262 "A bill to repeal the excise tax on medical device manufacturers."
Support for H.R. 436, Health Care Cost Reduction Act of 2012.
Support for H.R. 436, Health Care Cost Reduction Act of 2012, and S.17, Medical Device Access and Innovation Protection Act.
Support for H.R. 436, Health Care Cost Reduction Act of 2012, H.R. 1004, Medical FSA Improvement Act of 2011 and S.1404, Medical FSA Improvement Act of 2011.
Medicare Decisions Accountability Act of 2011
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: THE MCMANUS GROUP
Medicare Part D issues. Support for S.668 "Health Care Bureaucrats Elimination Act" and H.R.452 "Medicare Decisions Accountability Act of 2011."
Medicare Decisions Accountability Act of 2011
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: THE MCMANUS GROUP
Medicare Part D issues. Support for S.668 "Health Care Bureaucrats Elimination Act" and H.R.452 "Medicare Decisions Accountability Act of 2011."
USPSTF Transparency and Accountability Act of 2012
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION · Firm: THE MCMANUS GROUP
Opposition to the U.S. Preventative Services Task Force (USPSTF) recommendation regarding the prostate-specific antigen test. Promotion of greater transparency of USPSTF. Support for H.R. 5998, "USPSTF Transparency and Accountability Act of 2012."
USPSTF Transparency and Accountability Act of 2012
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION · Firm: THE MCMANUS GROUP
Opposition to the U.S. Preventative Services Task Force (USPSTF) recommendation regarding the prostate-specific antigen test. Promotion of greater transparency of USPSTF. Support for H.R. 5998, "USPSTF Transparency and Accountability Act of 2012."
USPSTF Transparency and Accountability Act of 2012
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION · Firm: THE MCMANUS GROUP
Opposition to the U.S. Preventative Services Task Force (USPSTF) recommendation regarding the prostate-specific antigen test. Promotion of greater transparency of USPSTF. Support for H.R. 5998, "USPSTF Transparency and Accountability Act of 2012."
American Taxpayer Relief Act of 2012
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION · Firm: THE MCMANUS GROUP
Physician self-referral issues. Physician reimbursement under the Sustainable Growth Rate. Physician payment rule issues regarding radiation therapy and CMS rule RIN 0938AR11 regarding physician fee schedule. Section 601 of HR 8, "American Taxpayer Relief Act of 2012."
American Taxpayer Relief Act of 2012
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Reform of Medicare payments to, and quality reporting of, ambulatory surgery centers. Support for H.R. 2108 and S. 1173, "Ambulatory Surgery Center Quality and Access Act of 2011." Title VI of HR 8, "American Taxpayer Relief Act of 2012."
American Taxpayer Relief Act of 2012
Client: AMERICAN MEDICAL ASSOCIATION · Firm: THE MCMANUS GROUP
Reform of the sustainable growth rate formula for Medicare physician payments. Section 601 of HR 8, "American Taxpayer Relief Act of 2012."
College Student Relief Act of 2007
Client: AMERICAN MEDICAL ASSOCIATION · Firm: THE MCMANUS GROUP
Support for HR 5, "Protecting Access to Healthcare Act." Drug shortage issues. Issues relating to antibiotic development incentives in HR 2182 and S 1734, "Generating Antibiotic Incentives Now Act of 2011" (GAIN Act).
Health Flexible Spending Arrangements Improvements Act of 2012
Client: WEX HEALTH · Firm: THE MCMANUS GROUP
HR 1004 "The Medical Flexible Spending Account Improvement Act of 2011," S 1404, "Medical FSA Improvement Act of 2011."
Health Flexible Spending Arrangements Improvements Act of 2012
Client: WEX HEALTH · Firm: THE MCMANUS GROUP
HR 1004 "The Medical Flexible Spending Account Improvement Act of 2011," S 312 "Patients Freedom to Choose Act," HR 605 "Patients Freedom to Choose Act," and S 387 "A bill to amend title 37, United States Code, to provide flexible spending arrangements for members of uniformed services, and for other purposes."
Health Flexible Spending Arrangements Improvements Act of 2012
Client: WEX HEALTH · Firm: THE MCMANUS GROUP
HR 1004 "The Medical Flexible Spending Account Improvement Act of 2011," S 1404, "Medical FSA Improvement Act of 2011."
Health Flexible Spending Arrangements Improvements Act of 2012
Client: WEX HEALTH · Firm: THE MCMANUS GROUP
HR 1004 "The Medical Flexible Spending Account Improvement Act of 2011," S 312 "Patients Freedom to Choose Act," HR 605 "Patients Freedom to Choose Act."
Medicare Access to Rehabilitation Services Act of 2011
Client: AMERICAN OCCUPATIONAL THERAPY ASSOCIATION · Firm: THE MCMANUS GROUP
Extension of the therapy caps exceptions process. Support for H.R. 1546, "Medicare Access to Rehabilitation Services Act of 2011" and S. 829, "Medicare Access to Rehabilitation Services Act of 2011."
Medicare Access to Rehabilitation Services Act of 2011
Client: AMERICAN OCCUPATIONAL THERAPY ASSOCIATION · Firm: THE MCMANUS GROUP
Therapy cap provisions in H.R. 1546, "Medicare Access to Rehabilitation Services Act of 2011" and S. 829, "Medicare Access to Rehabilitation Services Act of 2011." Therapy cap provisions in H.R. 3630, "Middle Class Tax Relief & Job Creation Act of 2011" and H.R. 3765, the "Temporary Payroll Tax Cut Continuation Act of 2011."
Ambulatory Surgical Center Quality and Access Act of 2011
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Reform of Medicare payments to, and quality reporting of, ambulatory surgery centers. Support for HR 2108 and S 1173, "Ambulatory Surgery Center Quality and Access Act of 2011."
Ambulatory Surgical Center Quality and Access Act of 2011
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Reform of Medicare payments to, and quality reporting of, ambulatory surgery centers. Support for H.R. 2108 and S. 1173, "Ambulatory Surgery Center Quality and Access Act of 2011."
Ambulatory Surgical Center Quality and Access Act of 2011
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Reform of Medicare payments to, and quality reporting of, ambulatory surgery centers. Support for H.R. 2108 and S. 1173, "Ambulatory Surgery Center Quality and Access Act of 2011."
Novel Device Regulatory Relief Act of 2011
Client: GARY AND MARY WEST HEALTH INSTITUTE · Firm: THE MCMANUS GROUP
Implementation of P.L. 111-148, "Patient Protection and Affordable Care Act" and P.L. 111-152, "Reconciliation Act of 2010." FDA approval issues. De Novo reform and support for H.R. 3203, "Novel Device Regulatory Relief Act of 2011."
Novel Device Regulatory Relief Act of 2011
Client: GARY AND MARY WEST HEALTH INSTITUTE · Firm: THE MCMANUS GROUP
FDA approval issues. De Novo reform and support for H.R. 3203, "Novel Device Regulatory Relief Act of 2011."
Support for H.R. 3497, "MODDERN Cures Act of 2011."
Temporary Payroll Tax Cut Continuation Act of 2011
Client: AMERICAN MEDICAL ASSOCIATION · Firm: THE MCMANUS GROUP
Reform of the sustainable growth rate formula for Medicare physician payments in H.R. 3630, "Middle Class Tax Relief & Job Creation Act of 2011" and H.R. 3765, the "Temporary Payroll Tax Cut Continuation Act of 2011."
Temporary Payroll Tax Cut Continuation Act of 2011
Client: AMERICAN OCCUPATIONAL THERAPY ASSOCIATION · Firm: THE MCMANUS GROUP
Therapy cap provisions in H.R. 1546, "Medicare Access to Rehabilitation Services Act of 2011" and S. 829, "Medicare Access to Rehabilitation Services Act of 2011." Therapy cap provisions in H.R. 3630, "Middle Class Tax Relief & Job Creation Act of 2011" and H.R. 3765, the "Temporary Payroll Tax Cut Continuation Act of 2011."
Passage of H.R. 436, "Protect Medical Innovation Act."
Health Care Cost Reduction Act of 2012
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: THE MCMANUS GROUP
Support for H.R. 436 "Protect Medical Innovation Act," S. 17 "Medical Device Access and Innovation Protection Act," and S. 262 "A bill to repeal the excise tax on medical device manufacturers."
Support for HR 436, "Protect Medical Innovation Act."
Health Care Cost Reduction Act of 2012
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: THE MCMANUS GROUP
Support for H.R. 436, "Protect Medical Innovation Act."
Health Care Cost Reduction Act of 2012
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: THE MCMANUS GROUP
Passage of HR 436 "Protect Medical Innovation Act."
Support for H.R. 436, "Protect Medical Innovation Act."
Passage of H.R.436 "Protect Medical Innovation Act."
Health Care Cost Reduction Act of 2012
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: THE MCMANUS GROUP
Support for HR 436 "Protect Medical Innovation Act."
Medicare Decisions Accountability Act of 2011
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: THE MCMANUS GROUP
Medicare Part D issues. Passage of S 668 "Health Care Bureaucrats Elimination Act" and HR 452 "Medicare Decisions Accountability Act of 2011"
Medicare Decisions Accountability Act of 2011
Client: ELI LILLY AND COMPANY · Firm: THE MCMANUS GROUP
Opposition to Part D rebates. Support for H.R. 452, "Medicare Decisions Accountability Act of 2011" and S. 668, "Health Care Bureaucrats Elimination Act."
Medicare Decisions Accountability Act of 2011
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION · Firm: THE MCMANUS GROUP
Physician self-referral issues. Support for H.R.452 "Medicare Decisions Accountability Act of 2011" and S.668 "Health Care Bureaucrats Elimination Act." Physician reimbursement under the Sustainable Growth Rate.
Medicare coverage and payment of Part B drugs and biologicals. Support for H.R.452 Medicare Decisions Accountability Act of 2011 and S.668 Health Care Bureaucrats Elimination Act.
Medicare Decisions Accountability Act of 2011
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION · Firm: THE MCMANUS GROUP
Physician self-referral issues. Opposition to imaging payment cuts in the US-Korea Free Trade Agreement. Support for H.R.452 Medicare Decisions Accountability Act of 2011 and S.668 Health Care Bureaucrats Elimination Act.
Medicare coverage and payment of Part B drugs and biologicals. Support for H.R.452 "Medicare Decisions Accountability Act of 2011" and S.668 "Health Care Bureaucrats Elimination Act."
Medicare Decisions Accountability Act of 2011
Client: ELI LILLY AND COMPANY · Firm: THE MCMANUS GROUP
Opposition to Part D rebates. Support for H.R.452 Medicare Decisions Accountability Act of 2011 and S.668 Health Care Bureaucrats Elimination Act
Opposition to Part D rebates. Support for H.R.452 Medicare Decisions Accountability Act of 2011 and S.668 Health Care Bureaucrats Elimination Act.
Medicare Decisions Accountability Act of 2011
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: THE MCMANUS GROUP
Medicare Part D issues. Support for S.668 "Health Care Bureaucrats Elimination Act" and H.R.452 "Medicare Decisions Accountability Act of 2011"
Medicare coverage and payment of Part B drugs and biologicals. Support for H.R. 452 "Medicare Decisions Accountability Act of 2011" and S. 668 "Health Care Bureaucrats Elimination Act." 340B payment and implementation issues.
Opposition to Part D rebates. Passage of H.R. 452 "Medicare Decisions Accountability Act of 2011" and S.668 "Health Care Bureaucrats Elimination Act."
Medicare Decisions Accountability Act of 2011
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: THE MCMANUS GROUP
Medicare Part D issues. Support for S.668 "Health Care Bureaucrats Elimination Act" and H.R.452 "Medicare Decisions Accountability Act of 2011."
HR 1004 "The Medical Flexible Spending Account Improvement Act of 2011," S 312 "Patients Freedom to Choose Act," HR 605 "Patients Freedom to Choose Act."
HR 1004 "The Medical Flexible Spending Account Improvement Act of 2011," S 312 "Patients Freedom to Choose Act," HR 605 "Patients Freedom to Choose Act," and S 387 "A bill to amend title 37, United States Code, to provide flexible spending arrangements for members of uniformed services, and for other purposes."
To prohibit the sale of kitchen ranges or ovens which do not include a design, bracket, or other device which complies with an applicable consensus product safety standard intended to prevent the product from tipping.
Client: AMERICAN OCCUPATIONAL THERAPY ASSOCIATION · Firm: THE MCMANUS GROUP
Medicare coverage for occupational therapy services. H.R. 1049, "Medicare Home Health Flexibility Act of 2009." Therapy caps provisions in P.L. 111-148, "Patient Protection and Affordable Care Act" and P.L. 111-144, "Temporary Extension Act of 2010."
National Marine Mammal Research Program Act of 2009
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Reform of the Medicare ambulatory surgical center payment system. Support for H.R. 2029, "Ambulatory Surgical Center Access Act of 2009." ASC provisions in CMS-1404-P, CY2011 hospital outpatient department and ASC payment rule.
National Marine Mammal Research Program Act of 2009
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Reform of the Medicare ambulatory surgical center payment system. Support for H.R. 2029, "Ambulatory Surgical Center Access Act of 2009." ASC provisions in CMS-1404-P, CY2011 hospital outpatient department and ASC payment rule.
Ambulatory Surgical Center Access Act of 2009
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Reform of the Medicare ambulatory surgical center payment system. Support for H.R. 2049, "Ambulatory Surgical Center Access Act of 2009." ASC provisions in P.L. 111-148, "Patient Protection and Affordable Care Act." ASC provisions in H.R. 4803, "Patients' Right to Know Act."
Ambulatory Surgical Center Access Act of 2009
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Reform of the Medicare ambulatory surgical center payment system Support for H.R. 2049, "Ambulatory Surgical Center Access Act of 2009." ASC provisions in H.R. 4803, "Patients' Right to Know Act."
Reform of flexible spending accounts. Support for H.R. 2526, "Medical FSA Improvement Act of 2009."
Reform of flexible spending accounts. Support for H.R. 2526, "Medical FSA Improvement Act of 2009." Opposition to restrictions on FSA expenditures in P.L. 111-148, "Patient Protection and Affordable Care Act," and P.L. 111-152, "Reconciliation Act of 2010." Access to health savings accounts in P.L. 111-148, "Patient Protection and Affordable Care Act."
An Act to extend expiring provisions of the USA PATRIOT Improvement and Reauthorization Act of 2005 and Intelligence Reform and Terrorism Prevention Act of 2004 until February 28, 2011.
Client: AMERICAN MEDICAL ASSOCIATION · Firm: THE MCMANUS GROUP
Reform of the sustainable growth rate formula for Medicare physician payments Physician payment provisions in P.L. 111-148, "Patient Protection and Affordable Care Act," and P.L. 111-152, "Reconciliation Act of 2010." Support for H.R. 3961, "Medicare Physician Payment Reform Act of 2009," and S. 1776, "Medicare Physician Fairness Act of 2009." Independent Payment Advisory Board provisions in P.L. 111-148, "Patient Protection and Affordable Care Act" and P.L. 111-152, "Reconciliation Act of 2010."
Patients' Right to Know Act
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Reform of the Medicare ambulatory surgical center payment system Support for H.R. 2049, "Ambulatory Surgical Center Access Act of 2009." ASC provisions in H.R. 4803, "Patients' Right to Know Act."
Patients' Right to Know Act
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Reform of the Medicare ambulatory surgical center payment system. Support for H.R. 2049, "Ambulatory Surgical Center Access Act of 2009." ASC provisions in P.L. 111-148, "Patient Protection and Affordable Care Act." ASC provisions in H.R. 4803, "Patients' Right to Know Act."
Continuing Extension Act of 2010
Client: AMERICAN MEDICAL ASSOCIATION · Firm: THE MCMANUS GROUP
Reform of the sustainable growth rate formula for Medicare physician payments Physician payment provisions in H.R. 3962, "Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010," H.R. 4213, "American Jobs and Closing Tax Loopholes Act of 2010" and H.R. 4851, "Continuing Extension Act of 2010."
Medicare and Medicaid Extenders Act of 2010
Client: AMERICAN OCCUPATIONAL THERAPY ASSOCIATION · Firm: THE MCMANUS GROUP
Extension of the therapy caps exceptions process. Implementation of P.L. 111-148, "Patient Proection and Affordable Care Act," and P.L. 111-152, "Reconciliation Act of 2010." Therapy Payment Provisions in HR 4994, "Medicare and Medicaid Extenders Act of 2010," HR 5712, "Physician Payment and Therapy Relief Act of 2010," and the Multiple Procedure Payment Reduction provision in the 2011 Physician Fee Schedule rule.
Medicare and Medicaid Extenders Act of 2010
Client: AMERICAN MEDICAL ASSOCIATION · Firm: THE MCMANUS GROUP
Reform of the sustainable growth rate formula for Medicare physician payments. Physician payment provisions in H.R. 5712, "Physician Payment and Therapy Relief Act of 2010" and H.R. 4994, "Medicare and Medicaid Extenders Act of 2010."
Support for enhanced beneficiary copay assistance in H.R. 4994, Medicare and Medicaid Extenders Act of 2010 (Medicare Part D).
Healthy Communities through Helping to Offer Incentives and Choices to Everyone in Society Act of 2010
Client: ALLERGAN INC · Firm: THE MCMANUS GROUP
Implementation of P.L. 111-148, "Patient Protection and Affordable Care Act" and P.L. 111-152, "Reconciliation Act of 2010." FDA approval and enforcement issues. Issues related to obesity assessment and treatment. H.R. 5209, "Healthy Communities through Helping to Offer Incentives and Choices to Everyone in Society Act of 2010."
Healthy Communities through Helping to Offer Incentives and Choices to Everyone in Society Act of 2010
Client: ALLERGAN INC · Firm: THE MCMANUS GROUP
Implementation of P.L. 111-148, "Patient Protection and Affordable Care Act" and P.L. 111-152, "Reconciliation Act of 2010." FDA approval and enforcement issues. Issues related to obesity assessment and treatment. H.R. 5209, "Healthy Communities through Helping to Offer Incentives and Choices to Everyone in Society Act of 2010."
Physician Payment and Therapy Relief Act of 2010
Client: AMERICAN MEDICAL ASSOCIATION · Firm: THE MCMANUS GROUP
Reform of the sustainable growth rate formula for Medicare physician payments. Physician payment provisions in H.R. 5712, "Physician Payment and Therapy Relief Act of 2010" and H.R. 4994, "Medicare and Medicaid Extenders Act of 2010."
Physician Payment and Therapy Relief Act of 2010
Client: AMERICAN OCCUPATIONAL THERAPY ASSOCIATION · Firm: THE MCMANUS GROUP
Extension of the therapy caps exceptions process. Implementation of P.L. 111-148, "Patient Proection and Affordable Care Act," and P.L. 111-152, "Reconciliation Act of 2010." Therapy Payment Provisions in HR 4994, "Medicare and Medicaid Extenders Act of 2010," HR 5712, "Physician Payment and Therapy Relief Act of 2010," and the Multiple Procedure Payment Reduction provision in the 2011 Physician Fee Schedule rule.
Medicare Physician Fairness Act of 2009
Client: AMERICAN MEDICAL ASSOCIATION · Firm: THE MCMANUS GROUP
Reform of the sustainable growth rate formula for Medicare physician payments Physician payment provisions in P.L. 111-148, "Patient Protection and Affordable Care Act," and P.L. 111-152, "Reconciliation Act of 2010." Support for H.R. 3961, "Medicare Physician Payment Reform Act of 2009," and S. 1776, "Medicare Physician Fairness Act of 2009." Independent Payment Advisory Board provisions in P.L. 111-148, "Patient Protection and Affordable Care Act" and P.L. 111-152, "Reconciliation Act of 2010."
American Middle Class Tax (AMT) Relief Act of 2007
Client: ALLERGAN INC · Firm: THE MCMANUS GROUP
Opposition to medical device industry tax in P.L. 111-148, "Patient Protection and Affordable Care Act" and P.L. 111-152, "Reconciliation Act of 2010." Opposition to cosmetic surgery tax in H.R. 3590, "Patient Protection and Affordable Care Act."
Setting forth the congressional budget for the United States Government for fiscal year 2010 and including the appropriate budgetary levels for fiscal years 2009 and 2011 through 2014.
Client: AMERICAN MEDICAL ASSOCIATION · Firm: THE MCMANUS GROUP
Reform of the sustainable growth rate formula for Medicare physician payments. Support for physician payment provisions in H. Con. Res. 85 and S. Con. Res. 13, FY 2010 budget resolutions.
Medicare Home Health Flexibility Act of 2009
Client: AMERICAN OCCUPATIONAL THERAPY ASSOCIATION · Firm: THE MCMANUS GROUP
Medicare coverage for occupational therapy services. H.R. 1094, "Medicare Home Health Flexibility Act of 2009." Therapy provisions in H.R. 3962, "Affordable Health Care for America Act," and H.R. 3590, "Patient Protection and Affordable Care Act."
Medicare Home Health Flexibility Act of 2009
Client: AMERICAN OCCUPATIONAL THERAPY ASSOCIATION · Firm: THE MCMANUS GROUP
Medicare coverage for occupational therapy services. H.R. 1094, "Medicare Home Health Flexibility Act of 2009." Therapy provisions in H.R. 3200, "America's Affordable Health Choices Act of 2009."
Promoting Innovation and Access to Life-Saving Medicine Act
Client: ALLERGAN INC · Firm: THE MCMANUS GROUP
Issues related to follow-on biologics. Support for H.R. 1548, "Pathway for Biosimilars Act." Opposition to H.R. 1427, "Promoting Innovation and Access to Life-Saving Medicine Act." FDA approval and enforcement issues.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: AMGEN · Firm: THE MCMANUS GROUP
H.R. 1548, "Pathway for Biosimilars Act." H.R. 1427, "Promoting Innovation and Access to Life-Saving Medicine Act." Follow-on biologics provisions in H.R. 3200, "America's Affordable Health Choices Act of 2009" and S. ____, "America's Healthy Future Act."
Promoting Innovation and Access to Life-Saving Medicine Act
Client: ELI LILLY AND COMPANY · Firm: THE MCMANUS GROUP
Issues related to follow-on biologics. Support for H.R. 1548, "Pathway for Biosimilars Act." Opposition to H.R. 1427, "Promoting Innovation and Access to Life-Saving Medicine Act." Issues related to comparative effectiveness.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: ALLERGAN INC · Firm: THE MCMANUS GROUP
Follow-on biologics provisions in H.R. 3200, "America's Affordable Health Choices Act of 2009" and S. ____, "America's Healthy Future Act." Support for H.R. 1548, "Pathway for Biosimilars Act." Opposition to H.R. 1427, "Promoting Innovation and Access to Life-Saving Medicine Act." Issues related to obesity assessment and treatment.
Therapy cap provisions in H.R. 1546, "Medicare Access to Rehabilitation Services Act of 2011" and S. 829, "Medicare Access to Rehabilitation Services Act of 2011." Implementation of P.L. 112-96, "Middle Class Tax Relief and Job Creation Act of 2012," regarding therapy cap reforms.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SPIRACUR INC. via THE MCMANUS GROUP
2012 · fourth_quarter · 4T
Medicare coverage and reimbursement for negative pressure wound therapy devices. CMS rule RIN 0938-AR10 regarding hospital outpatient departments and CMS rule RIN 0938AR11 regarding physician fee schedule.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PEDIATRIX MEDICAL GROUP (MEDNAX NATIONAL MEDICAL GROUP) via THE MCMANUS GROUP
2012 · fourth_quarter · Q4
Implementation of health information technology payments for physicians in the Electronic Health Record Incentive Program.
Implementation of Medicare and Medicaid payments for primary care providers, CMS rule RIN 0938-AQ63 on Payments for Services Furnished by Certain Primary Care Physicians
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SPIRACUR INC. via THE MCMANUS GROUP
2012 · fourth_quarter · Q4
Medicare coverage and reimbursement for negative pressure wound therapy devices. CMS rule RIN 0938-AR10 regarding hospital outpatient departments and CMS rule RIN 0938AR11 regarding physician fee schedule.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via THE MCMANUS GROUP
2012 · fourth_quarter · Q4
Medicare Part D issues.
Implementation of P.L. 111-148, "Patient Protection and Affordable Care Act" and P.L. 111-152, "Reconciliation Act of 2010."
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via THE MCMANUS GROUP
2012 · fourth_quarter · Q4
Support for H.R. 436, Health Care Cost Reduction Act of 2012, and S.17, Medical Device Access and Innovation Protection Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH via THE MCMANUS GROUP
2012 · fourth_quarter · Q4
Medicare coverage and payment of Part B drugs and biologicals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LARGE UROLOGY GROUP PRACTICE ASSOCIATION via THE MCMANUS GROUP
2012 · fourth_quarter · Q4
Physician self-referral issues. Physician reimbursement under the Sustainable Growth Rate. Physician payment rule issues regarding radiation therapy and CMS rule RIN 0938AR11 regarding physician fee schedule. Section 601 of HR 8, "American Taxpayer Relief Act of 2012."
Opposition to the U.S. Preventative Services Task Force (USPSTF) recommendation regarding the prostate-specific antigen test. Promotion of greater transparency of USPSTF. Support for H.R. 5998, "USPSTF Transparency and Accountability Act of 2012."
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WEX HEALTH via THE MCMANUS GROUP
2012 · fourth_quarter · Q4
Support for H.R. 436, Health Care Cost Reduction Act of 2012, H.R. 1004, Medical FSA Improvement Act of 2011 and S.1404, Medical FSA Improvement Act of 2011.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELI LILLY AND COMPANY via THE MCMANUS GROUP
2012 · fourth_quarter · Q4
Implementation of P.L. 111-148, "Patient Protection and Affordable Care Act" and P.L. 111-152, "Reconciliation Act of 2010."
Opposition to Part D rebates.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · fourth_quarter · Q4
Implementation of Health Care Reform PL 111-148 Patient Protection and Affordable Care Act.
Medicare Part B drug reimbursement, including Sec. 632 of PL 112-240 "American Taxpayer Relief Act of 2012." Medicare Part D issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN MEDICAL ASSOCIATION via THE MCMANUS GROUP
2012 · fourth_quarter · Q4
Reform of the sustainable growth rate formula for Medicare physician payments. Section 601 of HR 8, "American Taxpayer Relief Act of 2012."
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN INC via THE MCMANUS GROUP
2012 · fourth_quarter · Q4
Support for H.R. 436, Health Care Cost Reduction Act of 2012, and S.17, Medical Device Access and Innovation Protection Act.
FDA approval and enforcement issues. Cosmetic safety issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GARY AND MARY WEST HEALTH INSTITUTE via THE MCMANUS GROUP
2012 · third_quarter · Q3
Medicare and Medicaid cost containment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PEDIATRIX MEDICAL GROUP (MEDNAX NATIONAL MEDICAL GROUP) via THE MCMANUS GROUP
2012 · third_quarter · Q3
Implementation of health information technology payments for physicians in the Electronic Health Record Incentive Program.
Implementation of Medicare and Medicaid payments for primary care providers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via THE MCMANUS GROUP
2012 · third_quarter · Q3
Support for H.R. 436, Health Care Cost Reduction Act of 2012, and S.17, Medical Device Access and Innovation Protection Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH via THE MCMANUS GROUP
2012 · third_quarter · Q3
FDA approval and enforcement issues.
Medicare coverage and payment of Part B drugs and biologicals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN OCCUPATIONAL THERAPY ASSOCIATION via THE MCMANUS GROUP
2012 · third_quarter · Q3
Therapy cap provisions in H.R. 1546, "Medicare Access to Rehabilitation Services Act of 2011" and S. 829, "Medicare Access to Rehabilitation Services Act of 2011." Implementation of P.L. 112-96, "Middle Class Tax Relief and Job Creation Act of 2012," regarding therapy cap reforms.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMBULATORY SURGERY CENTER ASSOCIATION via THE MCMANUS GROUP
2012 · third_quarter · Q3
Reform of Medicare payments to, and quality reporting of, ambulatory surgery centers. Support for H.R. 2108 and S. 1173, "Ambulatory Surgery Center Quality and Access Act of 2011."
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN INC via THE MCMANUS GROUP
2012 · third_quarter · Q3
Support for H.R. 436, Health Care Cost Reduction Act of 2012, and S.17, Medical Device Access and Innovation Protection Act.
FDA approval and enforcement issues. Cosmetic safety issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via THE MCMANUS GROUP
2012 · third_quarter · Q3
Implementation of P.L. 111-148, "Patient Protection and Affordable Care Act" and P.L. 111-152, "Reconciliation Act of 2010."
Medicare Part D issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SPIRACUR INC. via THE MCMANUS GROUP
2012 · third_quarter · Q3
Medicare coverage and reimbursement for negative pressure wound therapy devices.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
LARGE UROLOGY GROUP PRACTICE ASSOCIATION via THE MCMANUS GROUP
2012 · third_quarter · Q3
Physician self-referral issues. Physician reimbursement under the Sustainable Growth Rate. Physician payment rule issues regarding radiation therapy.
Opposition to the U.S. Preventative Services Task Force (USPSTF) recommendation regarding the prostate-specific antigen test. Promotion of greater transparency of USPSTF. Support for H.R. 5998, "USPSTF Transparency and Accountability Act of 2012."
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WEX HEALTH via THE MCMANUS GROUP
2012 · third_quarter · Q3
Support for H.R. 436, Health Care Cost Reduction Act of 2012, H.R. 1004, Medical FSA Improvement Act of 2011 and S.1404, Medical FSA Improvement Act of 2011.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELI LILLY AND COMPANY via THE MCMANUS GROUP
2012 · third_quarter · Q3
Implementation of P.L. 111-148, "Patient Protection and Affordable Care Act" and P.L. 111-152, "Reconciliation Act of 2010."
Opposition to Part D rebates.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · third_quarter · Q3
Medicare Part B drug reimbursement, including implementation of bundled payment for dialysis. Medicare Part D issues.
Implementation of Health Care Reform PL 111-148 Patient Protection and Affordable Care Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN MEDICAL ASSOCIATION via THE MCMANUS GROUP
2012 · third_quarter · Q3
Reform of the sustainable growth rate formula for Medicare physician payments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN OCCUPATIONAL THERAPY ASSOCIATION via THE MCMANUS GROUP
2012 · second_quarter · Q2
Therapy cap provisions in H.R. 1546, "Medicare Access to Rehabilitation Services Act of 2011" and S. 829, "Medicare Access to Rehabilitation Services Act of 2011." Implementation of P.L. 112-96, "Middle Class Tax Relief and Job Creation Act of 2012," regarding therapy cap reforms.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SPIRACUR INC. via THE MCMANUS GROUP
2012 · second_quarter · Q2
Medicare coverage and reimbursement for negative pressure wound therapy devices.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via THE MCMANUS GROUP
2012 · second_quarter · Q2
Implementation of P.L. 111-148, "Patient Protection and Affordable Care Act" and P.L. 111-152, "Reconciliation Act of 2010." Issues relating to S.3187, "Food and Drug Administration Safety and Innovation Act." S.AMDT.2107 to S.3187 regarding reimportation. S.AMDT.2109 to S.3187 to revoke the exclusivity of certain entities. S.AMDT.2111 to S.3187 regarding generic prescription drugs. Drug shortage issues.
Medicare Part D issues. Support for S.668 "Health Care Bureaucrats Elimination Act" and H.R.452 "Medicare Decisions Accountability Act of 2011."
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PEDIATRIX MEDICAL GROUP (MEDNAX NATIONAL MEDICAL GROUP) via THE MCMANUS GROUP
2012 · second_quarter · Q2
Implementation of health information technology payments for physicians in the proposed rule, "Medicare and Medicaid Programs; Electronic Health Record Incentive ProgramStage 2," [CMS-004-P; RIN 0938-AQ84]. Drug shortage issues in S.3187, Food and Drug Administration Safety and Innovation Act.
Implementation of Medicare and Medicaid payments for primary care providers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via THE MCMANUS GROUP
2012 · second_quarter · Q2
Support for H.R. 436, Health Care Cost Reduction Act of 2012, and S.17, Medical Device Access and Innovation Protection Act.
FDA approval issues. Issues relating to S.3187, Food and Drug Administration Safety and Innovation Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELI LILLY AND COMPANY via THE MCMANUS GROUP
2012 · second_quarter · Q2
Drug shortage issues. Issues relating to S.3187, Food and Drug Administration Safety and Innovation Act. Regulation regarding disclosure of physician relationships with pharmaceutical manufacturers.
Opposition to Part D rebates.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LARGE UROLOGY GROUP PRACTICE ASSOCIATION via THE MCMANUS GROUP
2012 · second_quarter · Q2
Opposition to the U.S. Preventative Services Task Force (USPSTF) recommendation regarding the prostate-specific antigen test. Promotion of greater transparency of USPSTF. Support for H.R. 5998, "USPSTF Transparency and Accountability Act of 2012."
Physician self-referral issues. Physician reimbursement under the Sustainable Growth Rate.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH via THE MCMANUS GROUP
2012 · second_quarter · Q2
FDA approval and enforcement issues. Issues relating to S.3187, Food and Drug Administration Safety and Innovation Act. Issues relating to antibiotic development incentives in HR 2182 and S 1734, "Generating Antibiotic Incentives Now Act of 2011" (GAIN Act). Skin cancer awareness.
Medicare coverage and payment of Part B drugs and biologicals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WEX HEALTH via THE MCMANUS GROUP
2012 · second_quarter · Q2
Support for H.R. 436, Health Care Cost Reduction Act of 2012, H.R. 1004, Medical FSA Improvement Act of 2011 and S.1404, Medical FSA Improvement Act of 2011.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMBULATORY SURGERY CENTER ASSOCIATION via THE MCMANUS GROUP
2012 · second_quarter · Q2
Reform of Medicare payments to, and quality reporting of, ambulatory surgery centers. Support for H.R. 2108 and S. 1173, "Ambulatory Surgery Center Quality and Access Act of 2011." Drug shortage issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · second_quarter · Q2
Implementation of Health Care Reform PL 111-148 Patient Protection and Affordable Care Act (Biosimilars, IPAB). Issues relating to S.3187, Food and Drug Administration Safety and Innovation Act.
Medicare Part B drug reimbursement, including implementation of bundled payment for dialysis. Medicare Part D issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN MEDICAL ASSOCIATION via THE MCMANUS GROUP
2012 · second_quarter · Q2
Drug shortage issues relating to S.3187, Food and Drug Administration Safety and Innovation Act.
Reform of the sustainable growth rate formula for Medicare physician payments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GARY AND MARY WEST HEALTH INSTITUTE via THE MCMANUS GROUP
2012 · second_quarter · Q2
De Novo reform and mobile medical applications in S.3187, Food and Drug Administration Safety and Innovation Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN INC via THE MCMANUS GROUP
2012 · second_quarter · Q2
Issues relating to S.3187, Food and Drug Administration Safety and Innovation Act. FDA approval and enforcement issues. Cosmetic safety issues.
Support for H.R. 436, Health Care Cost Reduction Act of 2012.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PEDIATRIX MEDICAL GROUP (MEDNAX NATIONAL MEDICAL GROUP) via THE MCMANUS GROUP
2012 · first_quarter · Q1
Implementation of health information technology payments for physicians. Drug shortage issues.
Implementation of Medicare and Medicaid payments for primary care providers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELI LILLY AND COMPANY via THE MCMANUS GROUP
2012 · first_quarter · Q1
Opposition to Part D rebates.
Support for H.R. 3497, "MODDERN Cures Act of 2011." PDUFA reauthorization. Drug shortage issues. BPCA and PREA reauthorization.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GARY AND MARY WEST HEALTH INSTITUTE via THE MCMANUS GROUP
2012 · first_quarter · Q1
FDA approval issues. De Novo reform and support for H.R. 3203, "Novel Device Regulatory Relief Act of 2011." MDUFA reauthorization. Support for Section 721 of the House MDUFA draft and Section 611 of the Senate MDUFA draft. Support for S. 2067, "Safe, Efficient, and Transparent Medical Device Approval Act." Congressional oversight of the memorandum of understanding between the FDA and FCC.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SPIRACUR INC. via THE MCMANUS GROUP
2012 · first_quarter · Q1
Medicare coverage for negative pressure wound therapy devices.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via THE MCMANUS GROUP
2012 · first_quarter · Q1
Medicare Part D issues. Support for S.668 "Health Care Bureaucrats Elimination Act" and H.R.452 "Medicare Decisions Accountability Act of 2011."
Implementation of P.L. 111-148, "Patient Protection and Affordable Care Act" and P.L. 111-152, "Reconciliation Act of 2010." PDUFA reauthorization. Drug shortage issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via THE MCMANUS GROUP
2012 · first_quarter · Q1
Support for H.R. 436 "Protect Medical Innovation Act," S. 17 "Medical Device Access and Innovation Protection Act," and S. 262 "A bill to repeal the excise tax on medical device manufacturers."
FDA approval issues. MDUFA reauthorization.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LARGE UROLOGY GROUP PRACTICE ASSOCIATION via THE MCMANUS GROUP
2012 · first_quarter · Q1
Physician self-referral issues. Physician reimbursement under the Sustainable Growth Rate. Support for S 2243, "Medicare Better Health Rewards Program Act of 2012"
Opposition to the U.S. Preventative Services Task Force (USPSTF) draft recommendation regarding the prostate-specific antigen test. Promotion of greater transparency of USPSTF.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH via THE MCMANUS GROUP
2012 · first_quarter · Q1
Medicare coverage and payment of Part B drugs and biologicals.
FDA approval and enforcement issues. PDUFA reauthorization. Issues relating to antibiotic development incentives in HR 2182 and S 1734, "Generating Antibiotic Incentives Now Act of 2011" (GAIN Act).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WEX HEALTH via THE MCMANUS GROUP
2012 · first_quarter · Q1
Implementation of P.L. 111-157, "Dodd-Frank Wall Street Reform and Consumer Protection Act" and the Board of Governors of the Federal Reserve System, "Debit Card Interchange Fees and Routing Final Rule." Interchange provisions for health care debit cards.
HR 1004 "The Medical Flexible Spending Account Improvement Act of 2011," S 1404, "Medical FSA Improvement Act of 2011."
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMBULATORY SURGERY CENTER ASSOCIATION via THE MCMANUS GROUP
2012 · first_quarter · Q1
Reform of Medicare payments to, and quality reporting of, ambulatory surgery centers. Support for H.R. 2108 and S. 1173, "Ambulatory Surgery Center Quality and Access Act of 2011." Drug shortage issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN OCCUPATIONAL THERAPY ASSOCIATION via THE MCMANUS GROUP
2012 · first_quarter · Q1
Therapy cap provisions in H.R. 1546, "Medicare Access to Rehabilitation Services Act of 2011" and S. 829, "Medicare Access to Rehabilitation Services Act of 2011." Therapy cap provisions in H.R. 3630, "Middle Class Tax Relief & Job Creation Act of 2012."
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · first_quarter · Q1
Implementation of Health Care Reform PL 111-148 Patient Protection and Affordable Care Act (Biosimilars, IPAB). PDUFA reauthorization.
Medicare Part B drug reimbursement. Medicare Part D issues. Extending minimum payment for bone mass measurement provision in H.R. 3630, "Middle Class Tax Relief & Job Creation Act of 2012."
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN MEDICAL ASSOCIATION via THE MCMANUS GROUP
2012 · first_quarter · Q1
Reform of the sustainable growth rate formula for Medicare physician payments in H.R. 3630, "Middle Class Tax Relief & Job Creation Act of 2012."
Support for HR 5, "Protecting Access to Healthcare Act." Drug shortage issues. Issues relating to antibiotic development incentives in HR 2182 and S 1734, "Generating Antibiotic Incentives Now Act of 2011" (GAIN Act).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN INC via THE MCMANUS GROUP
2012 · first_quarter · Q1
Support for H.R. 436, "Protect Medical Innovation Act" and S.17, "Medical Device Access and Innovation Protection Act."
Opposition to Part D rebates.
FDA approval and enforcement issues. MDUFA reauthorization. PDUFA reauthorization. Cosmetic safety issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PEDIATRIX MEDICAL GROUP (MEDNAX NATIONAL MEDICAL GROUP) via THE MCMANUS GROUP
2012 · first_quarter · RR
Physician reimbursement under Medicare and Medicaid. Health information technology issues affecting neonatologists, pediatricians and anesthesiologists. Drug shortage issues.
Physician reimbursement under Medicare and Medicaid. Health information technology issues affecting neonatologists, pediatricians and anesthesiologists. Drug shortage issues.
GARY AND MARY WEST HEALTH INSTITUTE via THE MCMANUS GROUP
2011 · fourth_quarter · Q4
FDA approval issues. De Novo reform and support for H.R. 3203, "Novel Device Regulatory Relief Act of 2011."
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SPIRACUR INC. via THE MCMANUS GROUP
2011 · fourth_quarter · Q4
Medicare coverage for negative pressure wound therapy devices.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
LARGE UROLOGY GROUP PRACTICE ASSOCIATION via THE MCMANUS GROUP
2011 · fourth_quarter · Q4
Opposition to the U.S. Preventative Services Task Force draft recommendation regarding the prostate-specific antigen test.
Physician self-referral issues. Physician reimbursement under the Sustainable Growth Rate.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELI LILLY AND COMPANY via THE MCMANUS GROUP
2011 · fourth_quarter · Q4
Support for H.R. 3497, "MODDERN Cures Act of 2011."
Opposition to Part D rebates.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via THE MCMANUS GROUP
2011 · fourth_quarter · Q4
Medicare Part D issues. Support for S.668 "Health Care Bureaucrats Elimination Act" and H.R.452 "Medicare Decisions Accountability Act of 2011."
Implementation of P.L. 111-148, "Patient Protection and Affordable Care Act" and P.L. 111-152, "Reconciliation Act of 2010." PDUFA reauthorization. Drug shortage issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via THE MCMANUS GROUP
2011 · fourth_quarter · Q4
Support for H.R. 436 "Protect Medical Innovation Act," S. 17 "Medical Device Access and Innovation Protection Act," and S. 262 "A bill to repeal the excise tax on medical device manufacturers."
FDA approval issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH via THE MCMANUS GROUP
2011 · fourth_quarter · Q4
FDA approval and enforcement issues. 340B payment and implementation issues.
Medicare coverage and payment of Part B drugs and biologicals. Support for H.R. 452 "Medicare Decisions Accountability Act of 2011" and S. 668 "Health Care Bureaucrats Elimination Act." 340B payment and implementation issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WEX HEALTH via THE MCMANUS GROUP
2011 · fourth_quarter · Q4
HR 1004 "The Medical Flexible Spending Account Improvement Act of 2011," S 1404, "Medical FSA Improvement Act of 2011."
Implementation of P.L. 111-157, "Dodd-Frank Wall Street Reform and Consumer Protection Act" and the Board of Governors of the Federal Reserve System, "Debit Card Interchange Fees and Routing Final Rule." Interchange provisions for health care debit cards.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMBULATORY SURGERY CENTER ASSOCIATION via THE MCMANUS GROUP
2011 · fourth_quarter · Q4
Reform of Medicare payments to, and quality reporting of, ambulatory surgery centers. Support for H.R. 2108 and S. 1173, "Ambulatory Surgery Center Quality and Access Act of 2011."
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN OCCUPATIONAL THERAPY ASSOCIATION via THE MCMANUS GROUP
2011 · fourth_quarter · Q4
Therapy cap provisions in H.R. 1546, "Medicare Access to Rehabilitation Services Act of 2011" and S. 829, "Medicare Access to Rehabilitation Services Act of 2011." Therapy cap provisions in H.R. 3630, "Middle Class Tax Relief & Job Creation Act of 2011" and H.R. 3765, the "Temporary Payroll Tax Cut Continuation Act of 2011."
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · fourth_quarter · Q4
Medicare Part B drug reimbursement. Medicare Part D issues.
Implementation of Health Care Reform PL 111-148 Patient Protection and Affordable Care Act (Biosimilars, IPAB).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN MEDICAL ASSOCIATION via THE MCMANUS GROUP
2011 · fourth_quarter · Q4
Reform of the sustainable growth rate formula for Medicare physician payments in H.R. 3630, "Middle Class Tax Relief & Job Creation Act of 2011" and H.R. 3765, the "Temporary Payroll Tax Cut Continuation Act of 2011."
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN INC via THE MCMANUS GROUP
2011 · fourth_quarter · Q4
Support for H.R. 436, "Protect Medical Innovation Act."
Opposition to Part D rebates.
FDA approval and enforcement issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH via THE MCMANUS GROUP
2011 · third_quarter · Q3
FDA approval and enforcement issues. 340B payment and implementation issues.
Medicare coverage and payment of Part B drugs and biologicals. Support for H.R.452 "Medicare Decisions Accountability Act of 2011" and S.668 "Health Care Bureaucrats Elimination Act."
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via THE MCMANUS GROUP
2011 · third_quarter · Q3
Medicare Part D issues. Support for S.668 "Health Care Bureaucrats Elimination Act" and H.R.452 "Medicare Decisions Accountability Act of 2011"
Implementation of P.L. 111-148, "Patient Protection and Affordable Care Act" and P.L. 111-152, "Reconciliation Act of 2010." PDUFA reauthorization. Drug shortage issues.
Support for patent reform legislation, S.23 "America Invents Act" and H.R.1249 "America Invents Act"
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN INC via THE MCMANUS GROUP
2011 · third_quarter · Q3
Passage of H.R. 436, "Protect Medical Innovation Act."
Opposition to Part D rebates. Passage of H.R. 452 "Medicare Decisions Accountability Act of 2011" and S.668 "Health Care Bureaucrats Elimination Act."
FDA approval and enforcement issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GARY AND MARY WEST HEALTH INSTITUTE via THE MCMANUS GROUP
2011 · third_quarter · Q3
Support for S. 756, "Medicare Data Access for Transparency and Accountability Act."
Implementation of P.L. 111-148, "Patient Protection and Affordable Care Act" and P.L. 111-152, "Reconciliation Act of 2010." FDA approval issues. De Novo reform and support for H.R. 3203, "Novel Device Regulatory Relief Act of 2011."
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SPIRACUR INC. via THE MCMANUS GROUP
2011 · third_quarter · Q3
Medicare coverage for negative pressure wound therapy devices.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via THE MCMANUS GROUP
2011 · third_quarter · Q3
Support for H.R. 436, "Protect Medical Innovation Act."
FDA approval issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LARGE UROLOGY GROUP PRACTICE ASSOCIATION via THE MCMANUS GROUP
2011 · third_quarter · Q3
Physician self-referral issues. Support for H.R.452 "Medicare Decisions Accountability Act of 2011" and S.668 "Health Care Bureaucrats Elimination Act." Physician reimbursement under the Sustainable Growth Rate.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WEX HEALTH via THE MCMANUS GROUP
2011 · third_quarter · Q3
HR 1004 "The Medical Flexible Spending Account Improvement Act of 2011," S 1404, "Medical FSA Improvement Act of 2011."
Implementation of P.L. 111-157, "Dodd-Frank Wall Street Reform and Consumer Protection Act" and the Board of Governors of the Federal Reserve System, "Debit Card Interchange Fees and Routing Final Rule." Interchange provisions for health care debit cards.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELI LILLY AND COMPANY via THE MCMANUS GROUP
2011 · third_quarter · Q3
Support for patent reform legislation, S. 23 "America Invents Act" and H.R. 1249 "America Invents Act."
Opposition to Part D rebates. Support for H.R. 452, "Medicare Decisions Accountability Act of 2011" and S. 668, "Health Care Bureaucrats Elimination Act."
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMBULATORY SURGERY CENTER ASSOCIATION via THE MCMANUS GROUP
2011 · third_quarter · Q3
Reform of Medicare payments to, and quality reporting of, ambulatory surgery centers. Support for H.R. 2108 and S. 1173, "Ambulatory Surgery Center Quality and Access Act of 2011."
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN OCCUPATIONAL THERAPY ASSOCIATION via THE MCMANUS GROUP
2011 · third_quarter · Q3
Extension of the therapy caps exceptions process. Support for H.R. 1546, "Medicare Access to Rehabilitation Services Act of 2011" and S. 829, "Medicare Access to Rehabilitation Services Act of 2011."
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · third_quarter · Q3
Medicare Part B reimbursement and coverage. Medicare Part D issues.
Implementation of Health Care Reform PL 111-148 Patient Protection and Affordable Care Act (Biosimilars, IPAB).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN MEDICAL ASSOCIATION via THE MCMANUS GROUP
2011 · third_quarter · Q3
Reform of the sustainable growth rate formula for Medicare physician payments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN OCCUPATIONAL THERAPY ASSOCIATION via THE MCMANUS GROUP
2011 · second_quarter · Q2
Extension of the therapy caps exceptions process.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELI LILLY AND COMPANY via THE MCMANUS GROUP
2011 · second_quarter · Q2
Opposition to Part D rebates. Support for H.R.452 Medicare Decisions Accountability Act of 2011 and S.668 Health Care Bureaucrats Elimination Act
Support for patent reform legislation, S 23 "America Invents Act" and HR 1249 "America Invents Act."
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMBULATORY SURGERY CENTER ASSOCIATION via THE MCMANUS GROUP
2011 · second_quarter · Q2
Ambulatory surgery center amendment to the US-Korea Free Trade Agreement.
Reform of Medicare payments to, and quality reporting of, ambulatory surgery centers. Support for HR 2108 and S 1173, "Ambulatory Surgery Center Quality and Access Act of 2011."
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH via THE MCMANUS GROUP
2011 · second_quarter · Q2
FDA approval and enforcement issues.
Medicare coverage and payment of Part B drugs and biologicals. Support for H.R.452 Medicare Decisions Accountability Act of 2011 and S.668 Health Care Bureaucrats Elimination Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GARY AND MARY WEST HEALTH INSTITUTE via THE MCMANUS GROUP
2011 · second_quarter · Q2
Implementation of P.L. 111-148, Patient Protection and Affordable Care Act and P.L. 111-152, Reconciliation Act of 2010. FDA approval issues.
Passage of S 756 Medicare Data Access for Transparency and Accountability Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via THE MCMANUS GROUP
2011 · second_quarter · Q2
FDA approval issues.
Support for HR 436 "Protect Medical Innovation Act."
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · second_quarter · Q2
Medicare Part B reimbursement and coverage. Medicare Part D issues. Implementation of Health Care Reform PL 111 148 Patient Protection and Affordable Care Act (Biosimilars, IPAB).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN INC via THE MCMANUS GROUP
2011 · second_quarter · Q2
FDA approval and enforcement issues.
Opposition to Part D rebates. Support for H.R.452 Medicare Decisions Accountability Act of 2011 and S.668 Health Care Bureaucrats Elimination Act.
Support for HR 436, "Protect Medical Innovation Act."
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SPIRACUR INC. via THE MCMANUS GROUP
2011 · third_quarter · RR
Medicare coverage and reimbursement.
LARGE UROLOGY GROUP PRACTICE ASSOCIATION via THE MCMANUS GROUP
2011 · second_quarter · Q2
Physician self-referral issues. Opposition to imaging payment cuts in the US-Korea Free Trade Agreement. Support for H.R.452 Medicare Decisions Accountability Act of 2011 and S.668 Health Care Bureaucrats Elimination Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WEX HEALTH via THE MCMANUS GROUP
2011 · second_quarter · Q2
Implementation of P.L. 111-157, "Dodd-Frank Wall Street Reform and Consumer Protection Act" and in proposed rulemaking of the Board of Governors of the Federal Reserve System, "Debit Card Interchange Fees and Routing Proposed Rule." Interchange provisions for health care debit cards.
HR 1004 "The Medical Flexible Spending Account Improvement Act of 2011," S 312 "Patients Freedom to Choose Act," HR 605 "Patients Freedom to Choose Act."
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN MEDICAL ASSOCIATION via THE MCMANUS GROUP
2011 · second_quarter · Q2
Reform of the sustainable growth rate formula for Medicare physician payments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via THE MCMANUS GROUP
2011 · second_quarter · Q2
Medicare Part D issues. Passage of S 668 "Health Care Bureaucrats Elimination Act" and HR 452 "Medicare Decisions Accountability Act of 2011"
Implementation of P.L. 111-148, "Patient Protection and Affordable Care Act" and P.L. 111-152, "Reconciliation Act of 2010."
Passage of patent reform legislation, S 23 "America Invents Act" and HR 1249 "America Invents Act."
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN OCCUPATIONAL THERAPY ASSOCIATION via THE MCMANUS GROUP
2011 · first_quarter · Q1
Extension of the therapy caps exceptions process. Implementation of P.L. 111-148, Patient Protection and Affordable Care Act and P.L. 111-152, Reconciliation Act of 2010" regarding therapy services, and the Multiple Procedure Payment Reduction provision in the 2011 Physician Fee Schedule rule.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMBULATORY SURGERY CENTER ASSOCIATION via THE MCMANUS GROUP
2011 · first_quarter · Q1
Reform of Medicare payments to, and quality reporting of, ambulatory surgery centers.
In support of H.R.4, "Comprehensive 1099 Taxpayer Protection and Repayment of Exchange Subsidy Overpayments Act of 2011"
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH via THE MCMANUS GROUP
2011 · first_quarter · Q1
Medicare coverage and payment of Part B products.
FDA approval and enforcement issues.
Filing targets: HOUSE OF REPRESENTATIVES
GARY AND MARY WEST HEALTH INSTITUTE via THE MCMANUS GROUP
2011 · first_quarter · Q1
PS Docket 10-255, "Framework for Next Generation 911 Deployment"
FDA approval and enforcement issues.
Implementation of the Center for Medicare and Medicaid Innovation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE